Literature DB >> 16765466

Factor Xa and thrombin evoke additive calcium and proinflammatory responses in endothelial cells subjected to coagulation.

Valéry Daubie1, Sandra Cauwenberghs, Nicole H M Senden, Roland Pochet, Theo Lindhout, Wim A Buurman, Johan W M Heemskerk.   

Abstract

Endothelial cells react to factor Xa and thrombin by proinflammatory responses. It is unclear how these cells respond under physiological conditions, where the serine proteases factor VIIa, factor Xa and thrombin are all simultaneously generated, as in tissue factor-driven blood coagulation. We studied the Ca(2+) signaling and downstream release of interleukins (ILs), induced by these proteases in monolayers of human umbilical vein endothelial cells. In single cells, factor Xa, but not factor VIIa, complexed with tissue factor, evoked a greatly delayed, oscillatory Ca(2+) response, which relied on its catalytic activity and resembled that of SLIGRL, a peptide specifically activating the protease-activated receptor 2 (PAR2). Thrombin even at low concentrations evoked a rapid, mostly non-oscillating Ca(2+) response through activation of PAR1, which reinforced the factor Xa response. The additive Ca(2+) signals persisted, when factor X and prothrombin were activated in situ, or in the presence of plasma that was triggered to coagulate with tissue factor. Further, thrombin reinforced the factor Xa-induced production of IL-8, but not of IL-6. Both interleukins were produced in the presence of coagulating plasma. In conclusion, under coagulant conditions, factor Xa and thrombin appear to contribute in different and additive ways to the Ca(2+)-mobilizing and proinflammatory reactions of endothelial cells. These data provide first evidence that these serine proteases trigger distinct signaling modules in endothelium that is activated by plasma coagulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16765466     DOI: 10.1016/j.bbamcr.2006.04.010

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  16 in total

1.  Factor Xa induces tissue factor expression in endothelial cells by P44/42 MAPK and NF-κB-dependent pathways.

Authors:  Rong Jiang; Ning-Ping Wang; Kenichi A Tanaka; Jerrold H Levy; Robert A Guyton; Zhi-Qing Zhao; Jakob Vinten-Johansen
Journal:  J Surg Res       Date:  2010-02-23       Impact factor: 2.192

Review 2.  Haemostatic system in inflammatory bowel diseases: new players in gut inflammation.

Authors:  Franco Scaldaferri; Stefano Lancellotti; Marco Pizzoferrato; Raimondo De Cristofaro
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

3.  High tissue factor activity and low tissue factor pathway inhibitor concentrations in patients with preterm labor.

Authors:  Offer Erez; Roberto Romero; Edi Vaisbuch; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Tinnakorn Chaiworapongsa; Francesca Gotsch; Jawed Fareed; Debra Hoppensteadt; Nandor Gabor Than; Bo Hyun Yoon; Sam Edwin; Zhong Dong; Jimmy Espinoza; Moshe Mazor; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2010-01

Review 4.  Protease-activated receptor signalling by coagulation proteases in endothelial cells.

Authors:  Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2014-07-03       Impact factor: 5.249

5.  Heparin-associated anti-Xa activity and platelet-derived prothrombotic and proinflammatory biomarkers in moderate to high-risk patients with acute coronary syndrome.

Authors:  Richard C Becker; Kenneth W Mahaffey; Hongqiu Yang; A J Marian; Mark I Furman; A Michael Lincoff; Stanley L Hazen; John L Petersen; Craig J Reist; Neal S Kleiman
Journal:  J Thromb Thrombolysis       Date:  2011-02       Impact factor: 2.300

6.  Beneficial Effect of Edoxaban on Preventing Atrial Fibrillation and Coagulation by Reducing Inflammation via HBG1/HBD Biomarkers.

Authors:  Chenguang Yang; Xiang Wang; Ying Guo; Xuyang Meng; Yi Li; Chenxi Xia; Lingbing Meng; Min Dong; Fang Wang
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

7.  Pyelonephritis during pregnancy: a cause for an acquired deficiency of protein Z.

Authors:  Jyh Kae Nien; Roberto Romero; Debra Hoppensteadt; Offer Erez; Jimmy Espinoza; Eleazar Soto; Juan Pedro Kusanovic; Francesca Gotsch; Chong Jai Kim; Pooja Mittal; Jawed Fareed; Joaquin Santolaya; Tinnakorn Chaiworapongsa; Samuel Edwin; Beth Pineles; Sonia Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2008-09

Review 8.  Interplay between inflammation and thrombosis in cardiovascular pathology.

Authors:  Konstantin Stark; Steffen Massberg
Journal:  Nat Rev Cardiol       Date:  2021-05-06       Impact factor: 32.419

9.  Evaluation of plaque stability of advanced atherosclerotic lesions in apo E-deficient mice after treatment with the oral factor Xa inhibitor rivaroxaban.

Authors:  Qianxing Zhou; Florian Bea; Michael Preusch; Hongjie Wang; Berend Isermann; Khurrum Shahzad; Hugo A Katus; Erwin Blessing
Journal:  Mediators Inflamm       Date:  2011-06-07       Impact factor: 4.711

Review 10.  The coagulation factor Xa/protease activated receptor-2 axis in the progression of liver fibrosis: a multifaceted paradigm.

Authors:  Keren Borensztajn; Jan H von der Thüsen; Maikel P Peppelenbosch; C Arnold Spek
Journal:  J Cell Mol Med       Date:  2009-11-28       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.